Baloxavir Superior to Placebo for Alleviating Flu Symptoms
WEDNESDAY, Sept. 5, 2018 — The selective inhibitor of influenza cap-dependent endonuclease, baloxavir marboxil, is superior to placebo for alleviating
Read more
WEDNESDAY, Sept. 5, 2018 — The selective inhibitor of influenza cap-dependent endonuclease, baloxavir marboxil, is superior to placebo for alleviating
Read more